(KN) Knowles Cor - Overview

Sector: Technology | Industry: Electronic Components | Exchange: NYSE (USA) | Market Cap: 2.176m USD | Total Return: 92.1% in 12m

Stock Microphones, Speakers, Capacitors, Filters
Total Rating 56
Safety 38
Buy Signal -0.01
Electronic Components -13.6
Electronic Components -22.6
Market Cap: 2,176m
Avg Trading Vol: 14.4M USD
ATR: 3.98%
Peers RS (IBD): 68.2
Risk 5d forecast
Volatility33.4%
Rel. Tail Risk-9.49%
Reward TTM
Sharpe Ratio1.43
Alpha43.18
Character TTM
Beta1.405
Beta Downside0.965
Drawdowns 3y
Max DD38.00%
CAGR/Max DD0.41
EPS (Earnings per Share) EPS (Earnings per Share) of KN over the last years for every Quarter: "2021-03": 0.29, "2021-06": 0.31, "2021-09": 0.45, "2021-12": 0.48, "2022-03": 0.35, "2022-06": 0.33, "2022-09": 0.25, "2022-12": 0.33, "2023-03": 0.05, "2023-06": 0.23, "2023-09": 0.31, "2023-12": 0.28, "2024-03": 0.2, "2024-06": 0.24, "2024-09": 0.26, "2024-12": 0.27, "2025-03": 0.18, "2025-06": 0.09, "2025-09": 0.33, "2025-12": 0.36,
EPS CAGR: 0.75%
EPS Trend: -6.5%
Last SUE: 0.32
Qual. Beats: 0
Revenue Revenue of KN over the last years for every Quarter: 2021-03: 201, 2021-06: 199.8, 2021-09: 233, 2021-12: 234.3, 2022-03: 201.4, 2022-06: 188, 2022-09: 178.2, 2022-12: 197.1, 2023-03: 144.3, 2023-06: 173, 2023-09: 108.1, 2023-12: 139.2, 2024-03: 133.3, 2024-06: 135.2, 2024-09: 142.5, 2024-12: 142.5, 2025-03: 132.199999, 2025-06: 145.9, 2025-09: 152.9, 2025-12: 162.2,
Rev. CAGR: -5.61%
Rev. Trend: -49.5%
Last SUE: 0.07
Qual. Beats: 0
Description: KN Knowles Cor

Knowles Corporation (KN) operates in the electronic components sector, specializing in capacitors, RF filters, balanced armature speakers, and medtech microphones. The company serves global markets including Asia, the United States, and Europe.

KN has two primary segments. The Precision Devices (PD) segment develops custom high-performance capacitors and RF solutions. These products are critical in defense, industrial, medtech, and electrification/energy sectors, where reliability and precise functionality are paramount. The Medtech & Specialty Audio (MSA) segment focuses on balanced armature speakers and microphones for hearing health and other specialized audio applications. This segment operates within a niche market requiring high-fidelity and miniature components.

The companys product portfolio includes film, electrolytic, and mica capacitors, essential components in various electronic systems. KNs business model involves selling to OEMs, contract manufacturers, suppliers, and distributors across diverse end markets such as defense, medtech, electric vehicles, and communications. The company was founded in 1946 and is headquartered in Itasca, Illinois.

To deepen your understanding of KNs financial performance and market position, consider exploring its detailed analytics on ValueRay.

Headlines to Watch Out For
  • Defense spending increases drive Precision Devices segment growth
  • Medtech microphone demand rises with aging global population
  • Specialty audio market expansion boosts MSA segment revenue
  • Capacitor sales impacted by electric vehicle production volatility
Piotroski VR‑10 (Strict) 8.0
Net Income: 44.2m TTM > 0 and > 6% of Revenue
FCF/TA: 0.08 > 0.02 and ΔFCF/TA -2.63 > 1.0
NWC/Revenue: 31.27% < 20% (prev 29.59%; Δ 1.68% < -1%)
CFO/TA 0.11 > 3% & CFO 114.0m > Net Income 44.2m
Net Debt (96.1m) to EBITDA (109.6m): 0.88 < 3
Current Ratio: 2.75 > 1.5 & < 3
Outstanding Shares: last quarter (87.3m) vs 12m ago -3.11% < -2%
Gross Margin: 41.30% > 18% (prev 0.40%; Δ 4.09k% > 0.5%)
Asset Turnover: 54.69% > 50% (prev 49.50%; Δ 5.19% > 0%)
Interest Coverage Ratio: 7.88 > 6 (EBITDA TTM 109.6m / Interest Expense TTM 9.30m)
Altman Z'' -2.80
A: 0.18 (Total Current Assets 291.4m - Total Current Liabilities 105.9m) / Total Assets 1.05b
B: -0.54 (Retained Earnings -569.4m / Total Assets 1.05b)
C: 0.07 (EBIT TTM 73.3m / Avg Total Assets 1.08b)
D: -2.52 (Book Value of Equity -693.1m / Total Liabilities 275.3m)
Altman-Z'' Score: -2.80 = D
Beneish M -3.13
DSRI: 0.91 (Receivables 102.8m/105.0m, Revenue 593.2m/553.5m)
GMI: 0.96 (GM 41.30% / 39.71%)
AQI: 1.03 (AQ_t 0.57 / AQ_t-1 0.55)
SGI: 1.07 (Revenue 593.2m / 553.5m)
TATA: -0.07 (NI 44.2m - CFO 114.0m) / TA 1.05b)
Beneish M-Score: -3.13 (Cap -4..+1) = AA
What is the price of KN shares? As of April 04, 2026, the stock is trading at USD 25.68 with a total of 360,442 shares traded.
Over the past week, the price has changed by +1.69%, over one month by -1.49%, over three months by +15.54% and over the past year by +92.06%.
Is KN a buy, sell or hold? Knowles Cor has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy KN.
  • StrongBuy: 2
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • StrongSell: 0
What are the forecasts/targets for the KN price?
Wallstreet Target Price 28.5 11%
Analysts Target Price 28.5 11%
KN Fundamental Data Overview as of 04 April 2026
P/E Trailing = 43.8621
P/E Forward = 11.9332
P/S = 3.668
P/B = 2.668
P/EG = 1.12
Revenue TTM = 593.2m USD
EBIT TTM = 73.3m USD
EBITDA TTM = 109.6m USD
Long Term Debt = 114.0m USD (from longTermDebt, last quarter)
Short Term Debt = 4.10m USD (from shortTermDebt, last quarter)
Debt = 150.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 96.1m USD (from netDebt column, last quarter)
Enterprise Value = 2.27b USD (2.18b + Debt 150.3m - CCE 54.2m)
Interest Coverage Ratio = 7.88 (Ebit TTM 73.3m / Interest Expense TTM 9.30m)
EV/FCF = 27.74x (Enterprise Value 2.27b / FCF TTM 81.9m)
FCF Yield = 3.60% (FCF TTM 81.9m / Enterprise Value 2.27b)
FCF Margin = 13.81% (FCF TTM 81.9m / Revenue TTM 593.2m)
Net Margin = 7.45% (Net Income TTM 44.2m / Revenue TTM 593.2m)
Gross Margin = 41.30% ((Revenue TTM 593.2m - Cost of Revenue TTM 348.2m) / Revenue TTM)
Gross Margin QoQ = 42.23% (prev 43.23%)
Tobins Q-Ratio = 2.16 (Enterprise Value 2.27b / Total Assets 1.05b)
Interest Expense / Debt = 1.20% (Interest Expense 1.80m / Debt 150.3m)
Taxrate = 13.85% (4.10m / 29.6m)
NOPAT = 63.1m (EBIT 73.3m * (1 - 13.85%))
Current Ratio = 2.75 (Total Current Assets 291.4m / Total Current Liabilities 105.9m)
Debt / Equity = 0.19 (Debt 150.3m / totalStockholderEquity, last quarter 775.8m)
Debt / EBITDA = 0.88 (Net Debt 96.1m / EBITDA 109.6m)
Debt / FCF = 1.17 (Net Debt 96.1m / FCF TTM 81.9m)
Total Stockholder Equity = 757.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.08% (Net Income 44.2m / Total Assets 1.05b)
RoE = 5.84% (Net Income TTM 44.2m / Total Stockholder Equity 757.4m)
RoCE = 8.41% (EBIT 73.3m / Capital Employed (Equity 757.4m + L.T.Debt 114.0m))
RoIC = 6.83% (NOPAT 63.1m / Invested Capital 924.6m)
WACC = 10.29% (E(2.18b)/V(2.33b) * Re(10.93%) + D(150.3m)/V(2.33b) * Rd(1.20%) * (1-Tc(0.14)))
Discount Rate = 10.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.20%
[DCF] Terminal Value 71.37% ; FCFF base≈95.7m ; Y1≈100.5m ; Y5≈117.4m
[DCF] Fair Price = 15.52 (EV 1.42b - Net Debt 96.1m = Equity 1.33b / Shares 85.5m; r=10.29% [WACC]; 5y FCF grow 5.32% → 3.0% )
EPS Correlation: -6.53 | EPS CAGR: 0.75% | SUE: 0.32 | # QB: 0
Revenue Correlation: -49.49 | Revenue CAGR: -5.61% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.29 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=4
EPS current Year (2026-12-31): EPS=1.24 | Chg7d=+0.018 | Chg30d=+0.018 | Revisions Net=+0 | Growth EPS=+11.7% | Growth Revenue=+6.2%
EPS next Year (2027-12-31): EPS=1.50 | Chg7d=+0.030 | Chg30d=-0.003 | Revisions Net=+2 | Growth EPS=+20.7% | Growth Revenue=+7.0%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.7% (Discount Rate 10.9% - Earnings Yield 2.3%)
[Growth] Growth Spread = -3.7% (Analyst 4.9% - Implied 8.7%)
External Resources
Dataroma Stockcircle